ERBB2 and breast carcinoma: Xia et al. found that, in contrast to HER2-targeted CAR-NK cells, HER2-targeted CAR-NK cells coexpressing sPD-1 demonstrated increased cytotoxicity against HER2-positive breast cancer cells with strong HER2 and PD-L1 expression [165].